Understanding how repeat RNA affects tumor immunity
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
This study is looking at how certain RNA sequences in cancer cells can affect the immune system's ability to fight tumors, with the hope that this could lead to better cancer treatments for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10913484 on NIH RePORTER |
What this research studies
This research investigates the role of repeat RNA in cancer cells and how it influences the immune response to tumors. By employing statistical physics methods, the team aims to understand how these RNA sequences can stimulate the innate immune system and potentially improve responses to cancer immunotherapies. The study will analyze the expression of repeat RNA in tumors compared to normal tissues and explore its correlation with treatment outcomes. Patients may benefit from insights that could lead to new therapeutic targets and biomarkers for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with various types of cancers, particularly those undergoing immunotherapy.
Not a fit: Patients with non-cancerous conditions or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer immunotherapy outcomes by identifying new biomarkers and therapeutic targets.
How similar studies have performed: Previous research has shown that targeting RNA elements in cancer can enhance immune responses, suggesting a promising avenue for this approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Greenbaum, Benjamin — Sloan-Kettering Inst Can Research
- Study coordinator: Greenbaum, Benjamin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.